Human Gene FAH (ENST00000561421.6) from GENCODE V44
  Description: Homo sapiens fumarylacetoacetate hydrolase (FAH), transcript variant 2, mRNA. (from RefSeq NM_000137)
RefSeq Summary (NM_000137): This gene encodes the last enzyme in the tyrosine catabolism pathway. FAH deficiency is associated with Type 1 hereditary tyrosinemia (HT). [provided by RefSeq, Jul 2008].
Gencode Transcript: ENST00000561421.6
Gencode Gene: ENSG00000103876.14
Transcript (Including UTRs)
   Position: hg38 chr15:80,152,999-80,186,349 Size: 33,351 Total Exon Count: 14 Strand: +
Coding Region
   Position: hg38 chr15:80,153,055-80,186,209 Size: 33,155 Coding Exon Count: 14 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
RNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsPathwaysOther NamesGeneReviewsMethods
Data last updated at UCSC: 2023-08-18 00:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr15:80,152,999-80,186,349)mRNA (may differ from genome)Protein (419 aa)
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaAlphaFold
BioGPSEnsemblEntrez GeneExonPrimerGencodeGeneCards
HGNCHPRDLynxMalacardsMGIneXtProt
OMIMPubMedReactomeUniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: FAAA_HUMAN
DESCRIPTION: RecName: Full=Fumarylacetoacetase; Short=FAA; EC=3.7.1.2; AltName: Full=Beta-diketonase; AltName: Full=Fumarylacetoacetate hydrolase;
CATALYTIC ACTIVITY: 4-fumarylacetoacetate + H(2)O = acetoacetate + fumarate.
COFACTOR: Calcium (By similarity).
COFACTOR: Magnesium (By similarity).
PATHWAY: Amino-acid degradation; L-phenylalanine degradation; acetoacetate and fumarate from L-phenylalanine: step 6/6.
SUBUNIT: Homodimer.
TISSUE SPECIFICITY: Mainly expressed in liver and kidney. Lower levels are also detected in many other tissues.
DISEASE: Defects in FAH are the cause of tyrosinemia type 1 (TYRO1) [MIM:276700]. An inborn error of metabolism characterized by elevations of tyrosine in the blood and urine, and hepatorenal manifestations. Typical features include hepatic necrosis, renal tubular injury, episodic weakness, self-mutilation, and seizures. Renal tubular dysfunction is associated with phosphate loss and hypophosphataemic rickets. Progressive liver disease can lead to the development of hepatocellular carcinoma. Dietary treatment with restriction of tyrosine and phenylalanine alleviates the rickets, but liver transplantation has so far been the only definite treatment.
SIMILARITY: Belongs to the FAH family.
WEB RESOURCE: Name=GeneReviews; URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/FAH";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: FAH
Diseases sorted by gene-association score: tyrosinemia, type i* (1716), tyrosinemia* (473), liver disease (24), tyrosinemia, type ii (17), hepatocellular carcinoma (12), alkaptonuria (11), tyrosinemia, type iii (9), rickets (9), spastic ataxia, charlevoix-saguenay type (7), amino acid metabolic disorder (7)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 33.02 RPKM in Liver
Total median expression: 292.71 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -13.9056-0.248 Picture PostScript Text
3' UTR -42.10140-0.301 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR005959 - Fumarylacetoacetase
IPR002529 - Fumarylacetoacetase_C
IPR011234 - Fumarylacetoacetase_C-rel
IPR015377 - Fumarylacetoacetase_N

Pfam Domains:
PF09298 - Fumarylacetoacetase N-terminal
PF01557 - Fumarylacetoacetate (FAA) hydrolase family

ModBase Predicted Comparative 3D Structure on P16930
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
Genome BrowserGenome BrowserGenome BrowserGenome BrowserNo orthologNo ortholog
Gene Details     
Gene Sorter     
MGIRGDEnsemblEnsembl  
Protein SequenceProtein SequenceProtein SequenceProtein Sequence  
AlignmentAlignmentAlignmentAlignment  

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0003824 catalytic activity
GO:0004334 fumarylacetoacetase activity
GO:0005515 protein binding
GO:0016787 hydrolase activity
GO:0046872 metal ion binding

Biological Process:
GO:0006527 arginine catabolic process
GO:0006559 L-phenylalanine catabolic process
GO:0006572 tyrosine catabolic process
GO:0008152 metabolic process
GO:0009072 aromatic amino acid family metabolic process

Cellular Component:
GO:0005829 cytosol
GO:0070062 extracellular exosome


-  Descriptions from all associated GenBank mRNAs
  AK297965 - Homo sapiens cDNA FLJ51912 complete cds, highly similar to Fumarylacetoacetase (EC 3.7.1.2).
D28440 - Homo sapiens mRNA for fumarylacetoacetase, 5'UTR region.
AK313951 - Homo sapiens cDNA, FLJ94596, Homo sapiens fumarylacetoacetate hydrolase (fumarylacetoacetase)(FAH), mRNA.
JD079895 - Sequence 60919 from Patent EP1572962.
M55150 - Human fumarylacetoacetate hydrolase mRNA, complete cds.
CU678020 - Synthetic construct Homo sapiens gateway clone IMAGE:100017228 5' read FAH mRNA.
BC002527 - Homo sapiens fumarylacetoacetate hydrolase (fumarylacetoacetase), mRNA (cDNA clone MGC:1557 IMAGE:3139988), complete cds.
GQ891433 - Homo sapiens clone HEL-S-154 epididymis secretory sperm binding protein mRNA, complete cds.
BT007160 - Homo sapiens fumarylacetoacetate hydrolase (fumarylacetoacetase) mRNA, complete cds.
BX537608 - Homo sapiens mRNA; cDNA DKFZp686F13224 (from clone DKFZp686F13224).
X51728 - Human mRNA for fumarylacetoacetase (EC 3.7.1.2).
JD025634 - Sequence 6658 from Patent EP1572962.
JD034560 - Sequence 15584 from Patent EP1572962.
S63548 - fumaryl acetoacetate hydrolase {alternatively spliced L product} [human, mRNA Partial Mutant, 324 nt].
S63549 - fumaryl acetoacetate hydrolase {alternatively spliced S product} [human, mRNA Partial Mutant, 117 nt].
JD272566 - Sequence 253590 from Patent EP1572962.
JD392005 - Sequence 373029 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  KEGG - Kyoto Encyclopedia of Genes and Genomes
hsa00350 - Tyrosine metabolism
hsa01100 - Metabolic pathways

BioCyc Knowledge Library
TYRFUMCAT-PWY - L-tyrosine degradation

BioCarta from NCI Cancer Genome Anatomy Project
h_bard1Pathway - BRCA1-dependent Ub-ligase activity
h_atrbrcaPathway - Role of BRCA1, BRCA2 and ATR in Cancer Susceptibility

Reactome (by CSHL, EBI, and GO)

Protein P16930 (Reactome details) participates in the following event(s):

R-HSA-71181 fumarylacetoacetate => fumarate + acetoacetate
R-HSA-71182 Phenylalanine and tyrosine catabolism
R-HSA-6788656 Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism
R-HSA-71291 Metabolism of nitrogenous molecules
R-HSA-1430728 Metabolism

-  Other Names for This Gene
  Alternate Gene Symbols: B2R9X1, D3DW95, ENST00000561421.1, ENST00000561421.2, ENST00000561421.3, ENST00000561421.4, ENST00000561421.5, FAAA_HUMAN, NM_000137, P16930, uc002bfm.1, uc002bfm.2, uc002bfm.3, uc002bfm.4
UCSC ID: ENST00000561421.6
RefSeq Accession: NM_000137
Protein: P16930 (aka FAAA_HUMAN)
CCDS: CCDS10314.1

-  GeneReviews for This Gene
  GeneReviews article(s) related to gene FAH:
tyrosinemia (Tyrosinemia Type I)

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.